Personalized Cancer Treatment | Patient-Centered Cancer Care | Multidisciplinary Oncology Team | Innovative Cancer Research
Personalized Cancer Treatment
Personalized medicine is no longer just the future of medicine, it is here. Our NorthShore Kellogg Cancer Center patients benefit from individualized treatment plans and the most sophisticated genomic and tumor analysis that directs therapy to one’s own “personal” tumor characteristics.
And just as important as DNA, we personalize treatment based on each individual’s and each family’s needs, attending to nutritional, psychological, financial and social needs.
Patient-Centered Cancer Care
Kellogg Cancer Center’s collaborative approach to cancer care goes beyond medical treatment and provides a wide array of support services to patients and their families, including:
- Our Psychosocial Program provides services to help patients manage emotional and practical needs.
- NorthShore’s Integrative Medicine Program provides complementary therapies to help patients improve well-being, reduce stress and optimize cancer treatments.
- When patients are finished with their cancer treatment, our Living in the Future (LIFE) cancer survivorship program helps them adapt and focus on their future health and well-being.
NorthShore is certified by the American Society of Clinical Oncology (ASCO) Quality Oncology Practice Initiative (QOPI) as a premier medical provider for practicing the highest standards for quality cancer care. The Commission on Cancer has continuously accredited NorthShore as an Academic Comprehensive Cancer Program since 1981.
Multidisciplinary Oncology Team
At the Kellogg Cancer Center, we are truly dedicated to improving patient outcomes. We come together as a team of specialty trained physicians, nurses and healthcare professionals, with the most advanced technology and expertise, all working to provide the best possible care to each individual patient.
Kellogg Cancer Center has been designated by Blue Cross Blue Shield of Illinois as a Blue Distinction Center for Complex and Rare Cancers. The Blue Distinction program identifies hospitals with proven expertise in delivering specialty care. These accomplishments validate the team’s approach and underscore the quality, compassionate cancer care patients receive.
Innovative Cancer Research
From the quickly evolving world of immunotherapy, which we have made a priority and conducted a vast array of clinical trials, to surgical enhancements including robotic pancreatic cancer surgery, we ensure that our patients have access to the latest and most effective therapies.
As both a teaching and research-driven program, we are set apart from many other healthcare institutions. We are further differentiated by our close partnership with the University of Chicago Pritzker School of Medicine and its science faculty.